From March 26, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on March 27, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.97 CNY | +1.48% | +2.52% | -4.23% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.23% | 8.01B | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+19.00% | 249B | |
-1.88% | 216B | |
+11.58% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Tranche Update on Shanghai Fosun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2024.